Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

[Cytokinetics Inc.](/topic/$cytk)

### Sentiment: XX%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$cytk/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$cytk/time-series/sentiment.tsv)  
**Current Value**: XX%  
**Daily Average**: XX%  
**1 Week**: XXX% +33%  
**1 Month**: XXX% +11%  
**6 Months**: XXX% no change  
**1 Year**: XXX% +28%  
**1-Year High**: XXX% on 2025-04-22  
**1-Year Low**: XX% on 2024-12-06  

**Most Supportive Themes**
- **Cytokinetics Presents New SEQUOIA-HCM Analyses:** (35%) Cytokinetics presents new SEQUOIA-HCM analyses at ESC Heart Failure 2025, showing consistent Aficamten Efficacy.
- **Strength Meter Maps:** (15%) Users are discussing Cytokinetics Inc. (CYTK) using "Strength Meter Maps", providing positive commentary and supporting the stock with technical analysis.
  
**Most Critical Themes**
- **General Market Sentiment:** (50%)  General negative market sentiment is influencing commentary about Cytokinetics Inc. (CYTK).
  
Network engagement breakdown:  
| Network | Positive | %   | Neutral | %   | Negative | %  |
| ------- | -------- | -   | ------- | -   | -------- | -  |
| X       | XXXXX    | XX% | XXXXX   | XX% | XXX      | X% |
| Reddit  | XX       | X%  | X       | X%  | X        | X% |
| YouTube | X        | X%  | X       | X%  | X        | X% |
|         |          |     |         |     |          |    |
| Total   | XXXXX    | XX% | XXXXX   | XX% | XXX      | X% |

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

Cytokinetics Inc.

Sentiment: XX%

Sentiment Line Chart
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
1 Week: XXX% +33%
1 Month: XXX% +11%
6 Months: XXX% no change
1 Year: XXX% +28%
1-Year High: XXX% on 2025-04-22
1-Year Low: XX% on 2024-12-06

Most Supportive Themes

  • Cytokinetics Presents New SEQUOIA-HCM Analyses: (35%) Cytokinetics presents new SEQUOIA-HCM analyses at ESC Heart Failure 2025, showing consistent Aficamten Efficacy.
  • Strength Meter Maps: (15%) Users are discussing Cytokinetics Inc. (CYTK) using "Strength Meter Maps", providing positive commentary and supporting the stock with technical analysis.

Most Critical Themes

  • General Market Sentiment: (50%) General negative market sentiment is influencing commentary about Cytokinetics Inc. (CYTK).

Network engagement breakdown:

Network Positive % Neutral % Negative %
X XXXXX XX% XXXXX XX% XXX X%
Reddit XX X% X X% X X%
YouTube X X% X X% X X%
Total XXXXX XX% XXXXX XX% XXX X%
Cytokinetics Inc. (CYTK) Sentiment
/topic/$cytk/sentiment